Desoxyepothilone B (Bristol-Myers Squibb/Roche)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameDesoxyepothilone B (Bristol-Myers Squibb/Roche)
Drug Alias NameNSC-703147KOS-862R-1492
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsAlzheimer DiseaseProstatic NeoplasmsLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche LtdBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb SrlcompanyF. Hoffmann-La Roche LtdNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseProstatic NeoplasmsLung Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A